Balyasny Asset Management LLC Enzo Biochem Inc Transaction History

Balyasny Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$3.81 - $5.53 $110,611 - $160,546	-29,032 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.06 - $6.78 $13,621 - $18,251	-2,692 Reduced 8.49%	29,032 $151,000
Q1 2018 May 15, 2018	BUY	$5.43 - $8.36 $115,506 - $177,833	21,272 Added 203.52%	31,724 $174,000
Q4 2017 Feb 14, 2018	SELL	$8.15 - $10.55 $83,130 - $107,610	-10,200 Reduced 49.39%	10,452 $85,000
Q3 2017 Nov 14, 2017	BUY	$10.45 - $11.44 $215,813 - $236,258	20,652	20,652 $216,000

15.4M

2.3K

Ticker ENZ
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 48,720,500
Market Cap $32.2M
Description
Enzo Biochem, Inc., an integrated diagnostics, clinical lab, and life sciences company, researches, develops, manufactures, and markets diagnostic and research products based on genetic engineering, biotechnology, and molecular biology. It operates through three segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. Th...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.